Xencor
Lizett Scott is an accomplished Associate Scientist II at Xencor, with extensive experience in research positions spanning over a decade. At Xencor since May 2017, Lizett has progressed through various roles, contributing significantly to the company's research efforts. Previously at Neurona Therapeutics from June 2015 to May 2017, Lizett assessed the therapeutic potential of stem-cell therapies for neurological disorders as part of the preclinical team. Earlier experiences include roles at UCSF in immunology, Cedars-Sinai Medical Center in neurosurgery, and the Salk Institute for Biological Studies where Lizett participated in genetics research. Educationally, Lizett holds a Master of Science in Biological Sciences with a specialization in Regenerative Medicine from California Polytechnic State University-San Luis Obispo.
This person is not in any teams
This person is not in any offices
Xencor
2 followers
Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.